Skip to main content
. 2014 Aug 28;9(8):e106040. doi: 10.1371/journal.pone.0106040

Figure 7. Ssu72 dephosphorylates Ser5P and Ser7P in vitro.

Figure 7

(A) Fifty ng phosphorylated GST-CTD was incubated with 3.4 µg GST (lane 1), 0.2 µg SCP1 (lane 2), 0.2 µg, 1 µg, or 5 µg wild-type human Ssu72 (lanes 3–5), or 5 µg mutant (C12S) Ssu72 (lane 6), followed by Immunoblotting using the phospho CTD–specific antibodies 3E10 (Ser2P), 3E8 (Ser5P), and 4E12 (Ser7P) and an antibody against the CTD (8WG16). (B) Purified human Pol II was incubated with wild-type (lane 1) or mutant (C12S) Ssu72 (lane 2) and analyzed by Western blotting using phospho CTD–specific antibodies 3E10 (Ser2P), 3E8 (Ser5P), 4E12 (Ser7P), and 6D7 (Thr4P).